![Scott Bratman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Scott Bratman
Società | Posizione | Inizio | Fine |
---|---|---|---|
Adela, Inc.
![]() Adela, Inc. Finance/Rental/LeasingFinance Adela, Inc. is a company that is developing technology to accelerate the diagnosis and improve the management of cancer through blood tests for minimal residual disease (MRD) monitoring and multi-cancer early detection (MCED). The company is based in Branford, CT. The company's genome-wide methylome enrichment platform captures extensive, biologically-relevant genomic information to maximize test performance and improve treatment decisions. Adela's approach to MRD testing is tissue agnostic, eliminating the burden of acquiring a tumor sample. The CEO of the company is Scott Bratman. | Corporate Officer/Principal | - | - |
Direttore/Membro del Consiglio | - | - | |
Amministratore Delegato | - | 25/09/2023 | |
Presidente | - | - |
Storia della carriera di Scott Bratman
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Corporate Officer/Principal | 1 |
Settori
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Adela, Inc.
![]() Adela, Inc. Finance/Rental/LeasingFinance Adela, Inc. is a company that is developing technology to accelerate the diagnosis and improve the management of cancer through blood tests for minimal residual disease (MRD) monitoring and multi-cancer early detection (MCED). The company is based in Branford, CT. The company's genome-wide methylome enrichment platform captures extensive, biologically-relevant genomic information to maximize test performance and improve treatment decisions. Adela's approach to MRD testing is tissue agnostic, eliminating the burden of acquiring a tumor sample. The CEO of the company is Scott Bratman. | Finance |
- Borsa valori
- Insiders
- Scott Bratman
- Esperienza